Formation Bio
PrivateLast Round
Series D
Jun 26, 2024
Est. Valuation
$1B
Total Funding Raised
$713.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Formation Bio is a biotechnology company that operates an AI-native drug development platform to acquire, in-license, and accelerate the development of clinical-stage pharmaceutical assets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Formation Bio Comparables
Compare Formation Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Owkin | 77% | |
| Insilico Medicine | 73% | |
| Eli Lilly and Company | 73% |
Formation Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 26, 2024 | ||||
| Series C | Sep 30, 2021 | ||||
| Series B | Oct 31, 2018 | ||||
| Series B | Oct 1, 2018 | ||||
| Series A | Nov 16, 2017 | ||||
Seed | Nov 1, 2016 |
Key People
Founding team and executive leadership
Formation Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D |
| S32 | Series C |
| Maveron | Series A, Series B, Seed |
| SV Angel | Series D |
| Founder Collective | Series A, Series B, Seed |
| Thrive Capital | Series C, Series D, Series B |
| Streamlined Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 91% MoM, reaching 25.9K.
- Apr 2, 2025
Former Pfizer CSO Mikael Dolsten joins as advisor.
Formation Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Formation Bio's valuation, stock price, and market status.
Is Formation Bio a public or private company?
Formation Bio is a private company.
What is the current stock price of Formation Bio?
Formation Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Formation Bio worth (valuation)?
Valuation information for Formation Bio is not publicly available.
Can I buy Formation Bio stock?
Formation Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Formation Bio's last funding round?
Formation Bio's most recent funding round was Series D on June 1, 2024.
Who are the main investors in Formation Bio?
Key investors in Formation Bio include Andreessen Horowitz, Thrive Capital, Sequoia Capital.
Will Formation Bio IPO soon?
No public IPO plans have been announced for Formation Bio.
How can I track Formation Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Formation Bio's secondary market activity and sign up for updates.